Roger P. Dickinson

814 total citations
26 papers, 636 citations indexed

About

Roger P. Dickinson is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Roger P. Dickinson has authored 26 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Organic Chemistry and 7 papers in Pharmacology. Recurrent topics in Roger P. Dickinson's work include Inflammatory mediators and NSAID effects (7 papers), Protease and Inhibitor Mechanisms (6 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). Roger P. Dickinson is often cited by papers focused on Inflammatory mediators and NSAID effects (7 papers), Protease and Inhibitor Mechanisms (6 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). Roger P. Dickinson collaborates with scholars based in United Kingdom and United States. Roger P. Dickinson's co-authors include Peter E. Cross, M. J. PARRY, Michael J. Randall, Chris Barber, Kevin N. Dack, John P. Huggins, M. Jonathan Fray, Nicholas L. Occleston, Paul V. Fish and Peter F. Troke and has published in prestigious journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters and Thrombosis Research.

In The Last Decade

Roger P. Dickinson

26 papers receiving 592 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger P. Dickinson United Kingdom 15 266 215 121 105 83 26 636
Thomas Harrity United States 17 257 1.0× 611 2.8× 103 0.9× 107 1.0× 42 0.5× 23 1.1k
Judith M. Pisano United States 10 184 0.7× 289 1.3× 46 0.4× 125 1.2× 17 0.2× 16 616
David S. Weinstein United States 16 362 1.4× 343 1.6× 113 0.9× 109 1.0× 12 0.1× 34 918
James R. Pruitt United States 16 284 1.1× 197 0.9× 51 0.4× 16 0.2× 79 1.0× 22 700
Jih‐Lie Tseng United States 13 63 0.2× 248 1.2× 56 0.5× 34 0.3× 38 0.5× 26 569
Caroline Ballot France 13 155 0.6× 299 1.4× 46 0.4× 108 1.0× 15 0.2× 21 662
Mark T. Yates United States 13 85 0.3× 204 0.9× 49 0.4× 94 0.9× 91 1.1× 19 731
Ying K. Yee United States 16 291 1.1× 275 1.3× 95 0.8× 18 0.2× 19 0.2× 24 885
Zhouling Xie China 16 158 0.6× 277 1.3× 38 0.3× 42 0.4× 49 0.6× 46 643
Qianbin Li China 18 295 1.1× 467 2.2× 31 0.3× 63 0.6× 41 0.5× 66 886

Countries citing papers authored by Roger P. Dickinson

Since Specialization
Citations

This map shows the geographic impact of Roger P. Dickinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger P. Dickinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger P. Dickinson more than expected).

Fields of papers citing papers by Roger P. Dickinson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger P. Dickinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger P. Dickinson. The network helps show where Roger P. Dickinson may publish in the future.

Co-authorship network of co-authors of Roger P. Dickinson

This figure shows the co-authorship network connecting the top 25 collaborators of Roger P. Dickinson. A scholar is included among the top collaborators of Roger P. Dickinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger P. Dickinson. Roger P. Dickinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fish, Paul V., Chris Barber, David G. Brown, et al.. (2007). Selective Urokinase-Type Plasminogen Activator Inhibitors. 4. 1-(7-Sulfonamidoisoquinolinyl)guanidines. Journal of Medicinal Chemistry. 50(10). 2341–2351. 52 indexed citations
2.
Whitlock, Gavin A., Kevin N. Dack, Roger P. Dickinson, & Mark L. Lewis. (2007). A novel series of highly selective inhibitors of MMP-3. Bioorganic & Medicinal Chemistry Letters. 17(24). 6750–6753. 20 indexed citations
3.
Barber, Chris, Roger P. Dickinson, & Paul V. Fish. (2004). Selective urokinase-type plasminogen activator (uPA) inhibitors. Part 3: 1-Isoquinolinylguanidines. Bioorganic & Medicinal Chemistry Letters. 14(12). 3227–3230. 30 indexed citations
4.
Barber, Chris & Roger P. Dickinson. (2002). Selective urokinase-type plasminogen activator (uPA) inhibitors. Part 2: (3-Substituted-5-halo-2-pyridinyl)guanidines. Bioorganic & Medicinal Chemistry Letters. 12(2). 185–187. 15 indexed citations
5.
Barber, Chris, et al.. (2002). Selective urokinase-type plasminogen activator (uPA) inhibitors. Part 1: 2-Pyridinylguanidines. Bioorganic & Medicinal Chemistry Letters. 12(2). 181–184. 25 indexed citations
6.
Rawson, David J., Kevin N. Dack, Roger P. Dickinson, & Kim James. (2002). The design and synthesis of a novel series of indole derived selective ETA antagonists. Bioorganic & Medicinal Chemistry Letters. 12(2). 125–128. 33 indexed citations
7.
Walker, Donald K., Kevin N. Dack, Roger P. Dickinson, et al.. (2001). Absorption, distribution, metabolism, and excretion considerations in selection of orally active indole-containing endothelin antagonist.. PubMed. 29(11). 1424–31. 6 indexed citations
8.
Dack, Kevin N., Roger P. Dickinson, Clive Long, & John Steele. (1998). Thromboxane modulating agents. 4. Design and synthesis of 3-(2-[{(4-chlorophenyl)sulfonyl}amino]ethyl)benzenepropanoic acid derivatives as potent thromboxane receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 8(16). 2061–2066. 5 indexed citations
9.
Dickinson, Roger P., et al.. (1997). Vinyl glycosides in oligosaccharide synthesis (part 4): glycosidase-catalysed preparation of substituted allyl glycosides. Journal of the Chemical Society Perkin Transactions 1. 3357–3360. 9 indexed citations
11.
Dickinson, Roger P., et al.. (1996). Novel antifungal 2-aryl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol derivatives with high activity against Aspergillus fumigatus. Bioorganic & Medicinal Chemistry Letters. 6(16). 2031–2036. 75 indexed citations
12.
Dickinson, Roger P., et al.. (1996). Thromboxane modulating agents. 2. Thromboxane receptor antagonists derived from the thromboxane synthase inhibitor dazmegrel.. Bioorganic & Medicinal Chemistry Letters. 6(14). 1691–1696. 4 indexed citations
13.
Dickinson, Roger P., Kevin N. Dack, & John Steele. (1995). Thromboxane modulating agents. 1. Design of 1-[(arylsulfonyl)amino] alkylindole derivatives as dual thromboxane synthase inhibitor/thromboxane receptor antagonists.. Bioorganic & Medicinal Chemistry Letters. 5(24). 3017–3022. 10 indexed citations
14.
Gwilt, Michael, H. W. Dalrymple, Roger A. Burges, et al.. (1991). Electrophysiologic Properties of UK-66,914, a Novel Class III Antiarrhythmic Agent. Journal of Cardiovascular Pharmacology. 17(3). 376–385. 26 indexed citations
15.
Cross, Peter E., Roger P. Dickinson, M. J. PARRY, & Michael J. Randall. (1986). Selective thromboxane synthetase inhibitors. 3. 1H-Imidazol-1-yl-substituted benzo[b]furan-, benzo[b]thiophene- and indole-2- and 3-carboxylic acids. Journal of Medicinal Chemistry. 29(9). 1637–1643. 12 indexed citations
16.
Cross, Peter E., Roger P. Dickinson, M. J. PARRY, & Michael J. Randall. (1985). Selective thromboxane synthetase inhibitors. 1. 1-[(Aryloxy)alkyl]-1H-imidazoles. Journal of Medicinal Chemistry. 28(10). 1427–1432. 30 indexed citations
17.
Randall, Michael J., et al.. (1981). UK-37,248, A novel, selective thromboxane synthetase inhibitor with platelet anti-aggregatory and anti-thrombotic activity. Thrombosis Research. 23(1-2). 145–162. 96 indexed citations
18.
Barnish, I. T., Peter E. Cross, Roger P. Dickinson, M. J. PARRY, & Michael J. Randall. (1981). Cerebrovasodilatation through selective inhibition of the enzyme carbonic anhydrase. 3. 5-(Arylthio)-, 5-(arylsulfinyl)-, and 5-(arylsulfonyl)thiophene-2-sulfonamides. Journal of Medicinal Chemistry. 24(8). 959–964. 9 indexed citations
19.
Cross, Peter E., Roger P. Dickinson, M. J. PARRY, & Michael J. Randall. (1981). 3-(1-imidazolylmethyl) indoles: potent and selective inhibitors of human blood platelet thromboxane synthetase. Inflammation Research. 11(3). 274–280. 9 indexed citations
20.
Cross, Peter E., et al.. (1977). Compounds with gastric antisecretory activity. 1. Phenoxyalkylamines. Journal of Medicinal Chemistry. 20(10). 1317–1323. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026